Clinical characteristics and prognosis of mixed hepatocellular carcinoma and cholangiocarcinoma

VernacularTitle:混合型肝癌临床特点及近期预后分析
Author: Yiting HU ; Jian WU ; Xiao XU ; Jun YU ; Sheng YAN ; Mangli ZHANG ; Qinghong KE ; Weilin WANG ; Shusen ZHENG
Publication Type:Journal Article
Keywords: Liver neoplasms; Hepatectomy; Prognosis
From: Chinese Journal of General Surgery 2012;27(2):103-106
CountryChina
Language:Chinese
Abstract: Objective To analyze the clinical profile and short-term postoperative prognosis of mixed hepatocellular carcinoma and cholangiocarcinoma (mHCC-CC). Methods Clinical data of 17 mHCC-CC cases undergoing hepatectomy were retrospectively analyzed. Results Patients average age was 53 years (27～76 years).There were 11 males (64.7％) and 6 females.Ten patients (58.8％) were asymptomatic,twelve patients(70.6％ ) had positive serology for hepatitis B infection,serum AFP levels ＞25 ng/ml in 12 cases. Serum CA199 levels ≥ 37 U/ml in 4 cases. All patients underwent radical hepatectomy,including ＞ 1.5 cm safe margin and lymphadenectomy.The 6-,12-,and 18-months overall survival rate was 93.8％,86.5％ and 57.7％,respectively.The 100- and 200-day disease-free survival was 65.3％ and 43.5％.The median disease-free survival was 161 days. Conclusions mHCC-CC is difficult to diagnose preoperatively.The diagnosis depends on pathological examination.The main treatment was surgical resection.The prognosis of mixed primary liver cancer is poor and tends to recur early after hepatectomy.